ENANTA PHARMACEUTICALS
Live / Registered — Registered and renewed (as of 01 Nov 2024)
What this means for you
Registered since 17 Aug 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Aug 2024).
Record
- Serial number
- 78137400
- Registration number
- 2875563
- Mark type
- Stylized text
- Filed
- 20 Jun 2002
- Published for opposition
- 31 Dec 2002
- Registered
- 17 Aug 2004
- Next maintenance due
- 17 Aug 2024
- Attorney of record
- Joshua S. Jarvis, Esq.
Goods and services
- Class 042 — Scientific and technological services: research and development services in the field of identification of compounds as potential therapeutic products
Owner
- Enanta Pharmaceuticals, Inc., Watertown, MA, US
- Enanta Pharmaceuticals, Inc., Watertown, MA, US
- Enanta Pharmaceuticals, Inc., Watertown, MA, US
Prosecution history
- 01 Nov 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 01 Nov 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 01 Nov 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 01 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Aug 2024 — TEAS SECTION 8 & 9 RECEIVED
- 17 Aug 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 22 Feb 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Feb 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Feb 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Feb 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Feb 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Feb 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Sept 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 29 Sept 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 29 Sept 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED